Pharmaceutical Executive Daily: Idvynso Receives FDA Approval

Apr 22, 05:32 PM

Headliner
Share
Subscribe

In today’s Pharmaceutical Executive Daily, the FDA approves a new treatment for HIV-1 infection in adults, Amazon One Medical launches a GLP-1 weight management program, and a new report highlights which top-selling drugs are most at risk of supply shortages.

Share
Subscribe
Next
Pharmaceutical Executive Daily: UnitedHealth Raises Full-Year Profit Forecast
Top episodes
Healthcare Marketing Strategies for Reaching Diverse Audiences
by Pharmaceutical Executive
Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
by Pharmaceutical Executive
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
by Pharmaceutical Executive